Market Overview

Aqua Pennsylvania Plans $239M in Infrastructure Improvements for 2013


Just in time for the first day of Spring, Aqua Pennsylvania, Inc. (Aqua) today announced it plans to make $239 million in infrastructure improvements in Pennsylvania throughout 2013.

Aqua's planned capital spending across its Pennsylvania operating divisions includes:

* $185 million throughout its Southeastern Pennsylvania operating division, which comprises parts of Bucks, Chester, Delaware, and Montgomery counties * $2.5 million throughout its Susquehanna operating division, which comprises parts of Athens Township, and Athens, South Waverly and Sayre boroughs * $10 million throughout its White Haven operating division, which comprises parts of Wyoming, Lackawanna, Luzerne, Lehigh, Monroe, Northampton, Schuylkill, Susquehanna and Carbon counties * $13 million throughout its Honesdale operating division, which comprises parts of Lackawanna, Monroe, Pike and Wayne counties * $16 million throughout its Roaring Creek operating division, which comprises parts of Adams, Columbia, Cumberland, Juniata, Northumberland, Schuylkill and Snyder counties * $12 million throughout its Shenango operating division, which comprises parts of Lawrence, Mercer, Forest, Crawford, Venango, Clarion, Warren and Clearfield counties.

Posted-In: News Contracts


Related Articles (WTR)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

IMAX, Disney Announce New Deal on New IMAX 3D Space Film

RTI Biologics Announces Positive Clinical Results for BioCleanse-Processed BTB Allografts Used in ACL Reconstruction